ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 219

A Fibromyalgia Assessment Screening Tool on a Multidimensional Health Assessment Questionnaire (MDHAQ) Which Does Not Include a Self-Report RADAI Painful Joint Count (RADAI), FAST3nJC, Recognizes Fibromyalgia Similarly to Other FAST3 Indices Which Include a RADAI

Theodore Pincus1, Isabel Castrejon 2 and Joel Block 2, 1Division of Rheumatology, Rush University Medical Center, Chicago, IL, 2Rush University Medical Center, Chicago, IL

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: diagnosis and patient questionnaires, fibromyalgia, Osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Fibromyalgia & Other Clinical Pain Syndromes Poster

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Fibromyalgia (FM) generally is easily recognized, but a diagnosis may be difficult, particularly in patients with secondary FM who have other primary diagnoses. Criteria for FM initially were reported in 1990, and revised in 2010, 2011 and 2016. The 2 most recent criteria are based entirely on patient self-report, which is not collected in most routine clinical care, as multiple patient questionnaires are not feasible in busy clinical settings. MDHAQ/RAPID3 (multi-dimensional health assessment questionnaire/routine assessment of patient index data) is informative in all diseases studied. Cumulative indices based on MDHAQ scales known as FAST3 (fibromyalgia assessment screening tool3) recognize FM at levels of agreement with revised FM criteria of >80% and correlations of >0.80, p< 0.001), and might provide clues to recognize FM in patients with non-rheumatic diseases, as most components of the MDHAQ (as well as the HAQ) appear generic rather than disease-specific, other than a RADAI self-report painful joint count. Therefore, we analyzed a FAST3-nJC (no RADAI JC) index versus 2011 FM criteria as a reference standard, and compared to other FAST3 indices which include a painful RADAI JC.

Methods: All patients with all diagnoses complete an MDHAQ at all visits in routine care at one setting.  The self-report questionnaire to recognize the 2011 FM Criteria was added over a 6-month period to be completed by consecutive patients. The MDHAQ includes 0-10 scores for physical function, and pain and patient global visual analog scales (VAS), compiled into 0-30 RAPID3, as well as a 0–10 fatigue VAS, 0–54 self-report painful joint count, and 0–60 symptom checklist.  Each MDHAQ scale was analyzed for agreement with FM Criteria according to receiver-operator-characteristic (ROC) curves for area under the curve (AUC). Optimal cut points for each measure were identified, based on specificity and sensitivity, to develop optimal cumulative indices for clues to FM versus the 2011 Criteria as “gold standards.”

Results: Among 502 patients with complete data, primary ICD-10 diagnoses were FM in 49, OA in 74, RA in 78, SLE 88 and other rheumatic diseases in 213. Primary or secondary FM was identified in 131 (26%) who met 2011 FM criteria.  The 4 MDHAQ scales with the highest AUC vs FM Criteria (0.829-0.889) and optimal cut-points, were symptom checklist 16/60, RADAI JC 16/54, fatigue VAS 6/10, and pain VAS 6/10. FAST3 0-3 measures were calculated as 0 or 1 based on cut-points for each measure, FM=2 or 3: FAST3-P= symptom checklist+RADAI JC+pain VAS;  FAST3-F=symptom checklist+RADAI JC+fatigue VAS; FAST3nJC=symptom checklist+painVAS+fatigue VAS(no RADAI).  All FAST3 indices agreed with FM Criteria >80% and kappas were >0.58, indicating good agreement (Table).  Lowest agreement was seen for FAST3nJC, expected as FM criteria include a self-report painful joint count, but differences are small. 

Conclusion: FAST3nJC had slightly lesser agreement with 2011 and 2016 FM criteria than FAST3-P and FAST3-F but would appear satisfactory to provide clues to recognize FM in patients with non-rheumatic diseases, although a diagnosis of FM ultimately is made by a physician. 


Table FAST3 indices vs 2011 FM Criteria

Table. Percent agreement and kappa of 3 FAST3 -fibromyalgia assessment screening tool3- indices vs 2011 FM Criteria


Disclosure: T. Pincus, Helath Services, 7, Medical History Services LLC, 6, 7, 9, Medical history services LLC, 6, 7; I. Castrejon, None; J. Block, None.

To cite this abstract in AMA style:

Pincus T, Castrejon I, Block J. A Fibromyalgia Assessment Screening Tool on a Multidimensional Health Assessment Questionnaire (MDHAQ) Which Does Not Include a Self-Report RADAI Painful Joint Count (RADAI), FAST3nJC, Recognizes Fibromyalgia Similarly to Other FAST3 Indices Which Include a RADAI [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/a-fibromyalgia-assessment-screening-tool-on-a-multidimensional-health-assessment-questionnaire-mdhaq-which-does-not-include-a-self-report-radai-painful-joint-count-radai-fast3njc-recognizes-fibr/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-fibromyalgia-assessment-screening-tool-on-a-multidimensional-health-assessment-questionnaire-mdhaq-which-does-not-include-a-self-report-radai-painful-joint-count-radai-fast3njc-recognizes-fibr/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology